India is awaiting the results, with a positive hope, of five coronavirus vaccine candidates that are undergoing trials in the country.
In UK, among 43,448 people enrolled in Pfizer’s vaccine trial, six people died. Two of those people had received the vaccine and four had received a placebo. According to the briefing document, both vaccine recipients who died were older than 55. One person suffered a heart attack after the second dose of the vaccination and died three days later. The other person died from arteriosclerosis three days after the first dose.
India is conducting trials of two of the frontrunner vaccine candidates apart from the indigenous ones. India is conducting trials of the promising Oxford and AstraZeneca coronavirus vaccine candidate on one hand and the Russia-made Sputnik V, which also claims to be 95% effective like the Pfizer vaccine.
On the other hand, the indigenously developed vaccine by Bharat Biotech in collaboration with ICMR has already started the Phase 3 clinical trials. Another indigenously developed coronavirus vaccine by Zydus Cadila has also completed the Phase 2 clinical trial. Biological E. Ltd has started early Phase 1 and 2 human trials of its coronavirus vaccine candidate” says India Today.
“However, in India, no coronavirus vaccine testing company has published testing protocols”, says the Polish magazine what next. By law, companies must provide basic CTRI test data. Observers have noticed that registry entries are often incomplete and updates are rare. Contrary to the US and European services that issue authorizations for the use of the vaccine in emergency, Indian authorities have not clarified when such a practice may occur. This is of particular interest in the context of the activities of the Serum Institute, which intends to seek approval for the use of the vaccine in certain cases. The issue of vaccine safety is extremely important – not least, because India will have to provide vaccines to more than one billion of its citizens. The country will also be responsible for producing resources intended for the citizens of the world.